Behind the Black Box: The Dark Side of Big Pharma Research

Physician assistants (PAs) are licensed to practice medicine to provide many of the same services as a physician. And they may even train in dermatology. But what do we need to take into consideration when bringing a PA into a dermatology practice? Joining Dr. Michael Greenberg to discuss the ethics of this all-too-common situation is Dr. John Weiss, President and Co-Managing Partner at Georgia Dermatology Partners.

The FDA’s recent approval of aducanumab for the treatment of Alzheimer’s disease has been met with a controversial response. So what do we need to know about this new drug and its potential to treat this progressive neurological disorder? Dr. Jerome Lisk is joined by Dr. Peter Whitehouse from Case Western Reserve University to break down the approval of this new drug and what it could mean for patients.

The prevalence of social media has grown significantly over the past few decades, and within the field of medicine, we’ve seen a rise in dermatologists using these platforms to grow their professional network, improve patient care, and provide essential education. But what ethical challenges arise from a widespread social media presence, and how can we navigate those challenges? To find out, Dr. Michael Greenberg speaks with Dr. Dustin Portela about his online presence as 208SkinDoc.

Spa dermatology has morphed over the last 20 to 30 years, but not all of those changes benefited our patients. In fact, there are now several ethical and practical concerns when it comes to illegitimate med spas. Joining Dr. Matthew Keller to share those considerations and what we as dermatologists need to know so we can help guide our patients is board-certified dermatologist and cosmetic surgeon Dr. Joel Schlessinger.

With only 3% of practicing oncologists identifying as Black, and less than 5% identifying as Latinx, how can we ensure these patient populations are equally represented in medical practice? Dr. Jacob Sands meets with ASCO’s current President, Dr. Lori Pierce, a Professor of Radiation Oncology and Vice Provost for Academic and Faculty Affairs at the University of Michigan, to discuss ASCO’s plan to increase quality in cancer care and research.

The pandemic continues to wreak havoc across the world, but a new deep learning computer model may have discovered ten potential treatment options to combat COVID-19. Dr. Charles Turck sits down with Dr. Ping Zhang, who leads the Artificial Intelligence in Medicine Lab and a faculty member at the Translational Data Analytics Institute at The Ohio State University, to discuss his team's findings.

Published March 29, 2021

Thousands of Americans live with the debilitating aftereffects of stroke, such as arm and communication problems. This makes technological developments like brain-computer interfaces absolutely critical for stroke survivors, but some questions are beginning to arise regarding the ethics of this technology. So in order for us to fully pursue this advancement, it’s important that we address those ethical concerns, as Dr. Mijail Serruya explains.

Now that we’re several months into the pandemic, many states and counties are turning to the local data gathered on COVID-19 incidence to help inform their plans moving forward. But are those reports really the most accurate sources of information? To find out, Dr. Charles Turck is here to discuss a recent report discussing how disparities in access to COVID-19 testing sites may be skewing case estimates.

Published August, 19 2020

To find out how different racial and ethnic groups are being affected by the COVID-19 pandemic, Dr. Charles Turck joins us to analyze data that was collected by the COVID Racial Tracker.

Published July 24, 2020

With the growing amount of illicit pharmaceutical drugs and medical supplies filling the global market amid the COVID-19 pandemic, are we at risk of facing another public health crisis? Listen in as Dr. Charles Turck brings this troubling trend to light.

Published June 3, 2020